Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

AbbVie Inc (NYSE:ABBV)

61.00
Delayed Data
As of 4:00pm ET
 -0.20 / -0.33%
Today’s Change
45.45
Today|||52-Week Range
71.60
+2.97%
Year-to-Date
AbbVie (ABBV) Earnings Report: Q1 2016 Conference Call Transcript
8:07pm / TheStreet.com
3 Things to Watch in Gilead Sciences, Inc.'s First-Quarter Results
Apr 23 / MotleyFool.com
AbbVie (ABBV) Stock Price Target Hiked at Jefferies
4:53pm / TheStreet.com
AbbVie (ABBV) Likely to Beat on Q1 Earnings: Stock to Gain?
Apr 22 / Zacks.com
M&A: back with a bang
10:09am / FT.com
Roche (RHHBY) Beats on Q1 Sales, New Launches in Focus (revised)
Apr 21 / Zacks.com
Capture A Potential 35% Gain With This Fast-Growing Stock
Apr 28 / StreetAuthority
The Zacks Analyst Blog Highlights: Medivation, Synta, AbbVie, Gilead and Orexigen
Apr 21 / Zacks.com
Cramer: Worst May Be Over for Embattled Pharma
Apr 28 / TheStreet.com
Value, Yield a Must in 'Wade Boggs' Market
Apr 21 / TheStreet.com
Three pharma deals worth $45bn reignite M&A boom
Apr 28 / FT.com
Better Buy: Pfizer Inc. vs. AbbVie
Apr 21 / MotleyFool.com
$40 Billion Takeover Has Big Pharma Giddy
Apr 28 / TheStreet.com
Biotech Stock Roundup: Medivation Buyout Rumors Resurface, Synta Up on Merger Deal
Apr 20 / Zacks.com
AbbVie joins wave of pharma moves with Stemcentrx deal
Apr 28 / FT.com
Healthcare ETFs to Buy on Blockbuster J&J Q1 Results
Apr 20 / Zacks.com
The Zacks Analyst Blog Highlights: Biogen, Sarepta, Catalyst Pharmaceuticals, AbbVie ...
Apr 28 / Zacks.com
9 Health Names to Like Amid the Rhetoric
Apr 20 / TheStreet.com
Will Poor Earnings Bring Down the Market?
Apr 28 / TheStreet.com
What Earnings Season Shows So Far
Apr 19 / TheStreet.com
AbbVie (ABBV) Beats on 1Q Earnings, Lowers View on Deal
Apr 28 / Zacks.com
UK companies more likely to hire outside CEOs
Apr 18 / FT.com
AbbVie (ABBV) Tops 1Q Earnings Estimates, Announces Deal
Apr 28 / Zacks.com
4 Healthcare Stocks That Are Looking Cheap
Apr 17 / MotleyFool.com
AbbVie (ABBV) Stock Tumbles, Revises 2016 Outlook to Reflect Stemcentrx Acquisition
Apr 28 / TheStreet.com
UnitedHealth (UNH) May Beat Q1 Earnings: Will Stock Gain?
Apr 15 / Zacks.com
AbbVie (ABBV) Lagging In Pre-Market Activity
Apr 28 / TheStreet.com
Will J&J (JNJ) Pull a Surprise Again in Q1 Earnings?
Apr 15 / Zacks.com
Biotech Stock Roundup: Biogen Tops on Q1 Earnings, Sarepta, Catalyst Plunge on Regula...
Apr 27 / Zacks.com
AbbVie Reveals Positive Data on Combination HCV Therapy
Apr 14 / Zacks.com
Biotech Stock Gilead (GILD) Likely to Beat in Q1 Earnings
Apr 26 / Zacks.com
The Zacks Analyst Blog Highlights: Intercept, Clovis, AbbVie, Relypsa and Horizon Pha...
Apr 14 / Zacks.com
Worried About Social Security? Buy These 4 Stocks
Apr 26 / MotleyFool.com
AbbVie's Venclexta Notches FDA Win, But Investors Might Want To Temper Enthusiasm
Apr 13 / MotleyFool.com
5 Biotech Stocks to Bet on This Earnings Season
Apr 25 / Zacks.com
Biotech Stock Roundup: FDA Advisory Panels Say Yes to Intercept, No to Clovis
Apr 13 / Zacks.com
Healthcare: Britain, the test tube of the world
Apr 25 / FT.com
Roche/AbbVie's Lymphocytic Leukemia Drug Gets FDA Nod
Apr 12 / Zacks.com
This Big Pharma Stock Is Set to Profit From an Immunology Bonanza
Apr 25 / TheStreet.com
M&A deals worth $370bn torpedoed by Obama administration
Apr 07 / FT.com
Centene (CNC) Q1 Earnings: Surprise in Store for Stock?
Apr 25 / Zacks.com
US Treasury shatters Pfizer chief Ian Read's merger dreams
Apr 06 / FT.com
Aetna (AET) Q1 Earnings: Is a Surprise in Store for Stock?
Apr 25 / Zacks.com
Big pharma seeks digital solution to productivity problem
Apr 06 / FT.com
Big Drug Stocks to Report This Week: LLY, GSK, VRTX, BMY, ABBV
Apr 25 / Zacks.com
Drugmakers race to prescribe preventive migraine remedies
Apr 03 / FT.com
Goldman Sach's 5 Large-Cap Pharma Stock Favorites Ahead of Earnings
Apr 25 / TheStreet.com